Tolerance of didanosine as enteric-coated capsules versus buffered tablets

AIDS Patient Care STDS. 2004 Jun;18(6):329-31. doi: 10.1089/1087291041444087.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-HIV Agents / administration & dosage*
  • Anti-HIV Agents / adverse effects
  • Didanosine / administration & dosage*
  • Didanosine / adverse effects
  • Dosage Forms
  • Female
  • Gastrointestinal Diseases / chemically induced
  • Gastrointestinal Diseases / epidemiology
  • Gastrointestinal Diseases / prevention & control*
  • HIV Infections / drug therapy*
  • Humans
  • Male
  • Retrospective Studies

Substances

  • Anti-HIV Agents
  • Dosage Forms
  • Didanosine